- IN₹143.86bn
- IN₹128.11bn
- IN₹28.39bn
- 91
- 14
- 70
- 64
Annual income statement for Indegene, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9,663 | 16,646 | 23,061 | 25,896 | 28,393 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7,503 | 14,580 | 19,697 | 21,465 | 23,690 |
| Operating Profit | 2,160 | 2,066 | 3,364 | 4,431 | 4,703 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2,315 | 2,265 | 3,630 | 4,586 | 5,393 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,857 | 1,628 | 2,661 | 3,367 | 4,067 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1,494 | 1,648 | 2,661 | 3,367 | 4,067 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,494 | 1,648 | 2,661 | 3,367 | 4,067 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 7.39 | 8.3 | 11.1 | 14.9 | 16.6 |
| Dividends per Share |